13F-HR filed by Logos Global Management LP
Logos Global Management LP filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 46 holding rows worth $500,452,000.
- Accession
- 0001172661-20-001764
- Filer
- CIK 1792126
- Filed
- 2020-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2020
A holdings report, 46 entries on the cover page, a total value of $500,452,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $500,452,000 with VALUE read as thousands by filing date, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| FORMA THERAPEUTICS HLDGS INC | 34633R104 | SHS | 1,280,000 | $59,507,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 200,000 | $31,204,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 2,000,000 | $26,000,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 926,454 | $25,556,000 | thousands by filing date | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 666,894 | $20,293,000 | thousands by filing date | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 295,000 | $19,688,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 800,000 | $18,856,000 | thousands by filing date | |
| ARENA PHARMACEUTICALS INC | 040047607 | COM NEW | 268,500 | $16,902,000 | thousands by filing date | |
| APPLIED MOLECULAR TRANS INC | 03824M109 | COM | 664,186 | $16,698,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 850,000 | $16,558,000 | thousands by filing date | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 1,200,000 | $16,296,000 | thousands by filing date | |
| BIOXCEL THERAPEUTICS INC | 09075P105 | COM | 300,000 | $15,903,000 | thousands by filing date | |
| IMMUNOVANT INC | 45258J102 | COM | 625,000 | $15,219,000 | thousands by filing date | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 400,000 | $15,004,000 | thousands by filing date | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 456,426 | $14,568,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 455,000 | $14,383,000 | thousands by filing date | |
| BRISTOL-MYERS SQUIBB CO | 110122157 | RIGHT 99/99/9999 | 4,000,000 | $14,320,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 400,000 | $10,804,000 | thousands by filing date | |
| AKOUOS INC | 00973J101 | COM | 450,000 | $10,125,000 | thousands by filing date | |
| PRINCIPIA BIOPHARMA INC | 74257L108 | COM | 150,000 | $8,969,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 135,000 | $8,523,000 | thousands by filing date | |
| PASSAGE BIO INC | 702712100 | COM | 344,438 | $8,472,000 | thousands by filing date | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 410,000 | $7,499,000 | thousands by filing date | |
| CALLIDITAS THERAPEUTICS AB SPONSERED | 13124Q106 | ADS | 300,000 | $6,990,000 | thousands by filing date | |
| ObsEva SA | H5861P103 | COM | 1,165,000 | $6,862,000 | thousands by filing date | |
| GENERATION BIO CO | 37148K100 | COM | 325,000 | $6,825,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 562,900 | $6,811,000 | thousands by filing date | |
| IGM BIOSCIENCES INC | 449585108 | COM | 91,841 | $6,704,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 600,000 | $6,174,000 | thousands by filing date | |
| 89BIO INC | 282559103 | COM | 290,000 | $5,780,000 | thousands by filing date | |
| APTOSE BIOSCIENCES INC COM | 03835T200 | Stock | 750,000 | $4,733,000 | thousands by filing date | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 123,465 | $4,685,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 110,000 | $4,620,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 900,000 | $4,590,000 | thousands by filing date | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 155,000 | $4,498,000 | thousands by filing date | |
| LIFESCI ACQUISITION CORP | 53228P208 | UNIT 03/31/2025 | 400,000 | $4,400,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 150,000 | $3,140,000 | thousands by filing date | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 361,945 | $2,809,000 | thousands by filing date | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 121,128 | $2,116,000 | thousands by filing date | |
| CHARDAN HEALTHCR ACQSTN 2 CO | 15957T206 | UNIT 99/99/9999 | 200,000 | $2,100,000 | thousands by filing date | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 158,484 | $1,477,000 | thousands by filing date | |
| ARYA SCIENCES ACQUISTION CO | G31655114 | UNIT 06/09/2027 | 100,000 | $1,160,000 | thousands by filing date | |
| LUMOS PHARMA INC | 55028X109 | COM | 50,000 | $825,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 57,475 | $739,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 200,000 | $612,000 | thousands by filing date | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 12,600 | $455,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-20-001764 | this filing | 2020-08-14 | acceptance time not in the bulk data set |